Peripartum Cardiomyopathy

  • Vidya A. Thobbi
  • Abhijit V. Kulkarni


Peripartum cardiomyopathy (PPCM) is a rare syndrome of heart failure presenting in late pregnancy up to 5 months after delivery in absence of cardiac disease prior to pregnancy. Morbidity and mortality ranges from 5 to 32 %. In some the cardiac status may improve and return to normal, but in others it may progress to severe cardiac failure and even death. There may be a risk of recurrence of heart failure and death in subsequent pregnancies (Abboud et al., Int J Cardiol 118(3):295–303, 2007; Ansari et al., Clin Rev Allergy Immunol. 23:301–324, 2002; Arnold et al., Can J Cardiol 22(1):23–45, 2006; Baruteau et al., Int J Cardiol 144(1):143–145, 2010; Brar et al., Am J Cardiol 100(2):302–304, 2007).

This chapter provides an updated, comprehensive review of PPCM, including emerging insights into the etiology of this disorder as well as current treatment options.


Heart Failure Left Ventricular Function Endomyocardial Biopsy Subsequent Pregnancy Idiopathic Dilate Cardiomyopathy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Abboud J, Murad Y, Chen-Scarabelli C, Saravolatz L, Scarabelli TM. Peripartum cardiomyopathy: a comprehensive review. Int J Cardiol. 2007;118(3):295–303.CrossRefPubMedGoogle Scholar
  2. 2.
    Ansari AA, Fett JD, Carraway RE, Mayne AE, Onlamoon N, Sundstrom JB. Autoimmune mechanisms as the basis for human peripartum cardiomyopathy. Clin Rev Allergy Immunol. 2002;23:301–24 [PMID: 12402414].CrossRefPubMedGoogle Scholar
  3. 3.
    Arnold JM, Liu P, Demers C, et al. Canadian Cardiovascular Society. Canadian Cardiovascular Society consensus conference recommendation on heart failure 2006: diagnosis and management. Can J Cardiol. 2006;22(1):23–45.Google Scholar
  4. 4.
    Baruteau AE, Leurent G, Martins R, et al. Peripartum cardiomyopathy in the era of cardiac magnetic resonance imaging: first results and perspectives. Int J Cardiol. 2010;144(1):143–5.CrossRefPubMedGoogle Scholar
  5. 5.
    Brar SS, Khan SS, Sandhu GK, et al. Incidence, mortality, and racial differences in peripartum cardiomyopathy. Am J Cardiol. 2007;100(2):302–4.CrossRefPubMedGoogle Scholar
  6. 6.
    Burkett EL, Hershberger RE. Clinical and genetic issues in familial dilated cardiomyopathy. J Am Coll Cardiol. 2005;45(7):969–81.CrossRefPubMedGoogle Scholar
  7. 7.
    Cénac A, Simonoff M, Moretto P, Djibo A. A low plasma selenium is a risk factor for peripartum cardiomyopathy: a comparative study in Sahelian Africa. Int J Cardiol. 1992;36(1):57–9.CrossRefPubMedGoogle Scholar
  8. 8.
    Carlin AJ, Alfirevic Z, Gyte ML. Interventions for treating peripartum cardiomyopathy to improve outcomes for women and babies. Cochrane Database Syst Rev. 2010;(9):CD008589, p 216.Google Scholar
  9. 9.
    Chapa JB, Heiberger HB, Weinert L, Decara J, Lang RM, Hibbard JU. Prognostic value of echocardiography in peripartum cardiomyopathy. Obstet Gynecol. 2005;105(6):1303–8.CrossRefPubMedGoogle Scholar
  10. 10.
    Demakis JG, Rahimtoola S, Sutton GC, et al. Natural course of peripartum cardiomyopathy. Circulation. 1971;44(6):1053–61.CrossRefPubMedGoogle Scholar
  11. 11.
    de Jong JS, Rietveld K, van Lochem LT, Bouma BJ. Rapid left ventricular recovery after cabergoline treatment in a patient with peripartum cardiomyopathy. Eur J Heart Fail. 2009;1(2):220–2.CrossRefGoogle Scholar
  12. 12.
    Egan DJ, Bisanzo MC, Hutson HR. Emergency department evaluation and management of peripartum cardiomyopathy. J Emerg Med. 2009;36(2):141–7.CrossRefPubMedGoogle Scholar
  13. 13.
    Elkayam U, Tummala PP, Rao K, et al. Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy. N Engl J Med. 2001;344(21):1567–71.CrossRefPubMedGoogle Scholar
  14. 14.
    Elkayam U, Akhter MW, Singh H, Khan S, Bitar F, Hameed A, et al. Pregnancy associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation. Circulation. 2005;111(16):2050–5 [PMID: 15851613].CrossRefPubMedGoogle Scholar
  15. 15.
    Elliott P, Andersson B, Arbustini E, et al. Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Disease. Eur Heart J. 2008;29(2):270–6.CrossRefPubMedGoogle Scholar
  16. 16.
    Felker GM, Jaeger CJ, Klodas E, Thiemann DR, Hare JM, Hruban RH, et al. Myocarditis and long-term survival in peripartum cardiomyopathy. Am Heart J. 2000;140(5):785–91 [PMID: 11054626].CrossRefPubMedGoogle Scholar
  17. 17.
    Fett JD, Christie LG, Carraway RD, Murphy JG. Five-year prospective study of the incidence and prognosis of peripartum cardiomyopathy at a single institution. Mayo Clin Proc. 2005;80(12):1602–6 [PMID: 16342653].CrossRefPubMedGoogle Scholar
  18. 18.
    Fett J, Ansara A, Sundstrom J, Combs Jr G. Peripartum cardiomyopathy: a selenium disconnection and an autoimmune connection. Int J Cardiol. 2002;86(2):311–6.CrossRefPubMedGoogle Scholar
  19. 19.
    Gavaert S, van Belleghem Y, Bouchez S, et al. Acute and critically ill peripartum cardiomyopathy and “bridge to” therapeutic options: a single center experience with intra-aortic balloon pump, extra-corporeal membrane oxygenation and continuous-flow left ventricular assist devices. Crit Care. 2011;15(2):R93.CrossRefGoogle Scholar
  20. 20.
    Goulet B, McMillan T, Bellet S. Idiopathic myocardial degeneration associated with pregnancy and especially the puerperium. Am J Med Sci. 1937;194(2):185–99.CrossRefGoogle Scholar
  21. 21.
    Heart Failure Society of America. Executive summary: HFSA 2006 comprehensive heart failure practice guideline. J Card Fail. 2006;12(1):10–38.CrossRefGoogle Scholar
  22. 22.
    Hilfiker-Kleiner D, Sliwa K, Drexler H. Peripartum cardiomyopathy: recent insights in its pathophysiology. Trends Cardiovasc Med. 2008;18(5):173–9.CrossRefPubMedGoogle Scholar
  23. 23.
    Hilfiker-Kleiner D, Kaminski K, Podewski E, et al. A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell. 2007;128(3):589–600.CrossRefPubMedGoogle Scholar
  24. 24.
    Jahns BG, Stein W, Hilfiker-Kleiner D, Pieske B, Emons G. Peripartum cardiomyopathy—a new treatment option by inhibition of prolactin secretion. Am J Obstet Gynecol. 2008;199(4):e5–6.CrossRefPubMedGoogle Scholar
  25. 25.
    James P. A review of peripartum cardiomyopathy. Int J Clin Pract. 2004;58(4):363–5.CrossRefPubMedGoogle Scholar
  26. 26.
    Keogh A, Macdonald P, Spratt P, Marshman D, Larbalestier R, Kaan A. Outcome in peripartum cardiomyopathy after heart transplantation. J Heart Lung Transplant. 1994;13(2):202–7.PubMedGoogle Scholar
  27. 27.
    Lampert MB, Hibbard J, Weinert L, Briller J, Lindheimer M, Lang RM. Peripartum heart failure associated with prolonged tocolytic therapy. Am J Obstet Gynecol. 1992;168(2):493–5.CrossRefGoogle Scholar
  28. 28.
    Lata I, Gupta R, Sahu S, Singh H. Emergency management of decompensated peripartum cardiomyopathy. J Emerg Trauma Shock. 2009;2(2):124–8.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    McNamara DM, Holubkov R, Starling RC, et al. Controlled trial of intravenous immune globulins in recent-onset dilated cardiomyopathy. Circulation. 2001;103:2254–9.CrossRefPubMedGoogle Scholar
  30. 30.
    Melvin KR, Richardson PJ, Olsen EG, Daly K, Jackson G. Peripartum cardiomyopathy due to myocarditis. N Engl J Med. 1982;307(12):731–4.CrossRefPubMedGoogle Scholar
  31. 31.
    Midei MG, DeMent SH, Feldman AM, Hutchins GM, Baughman KL. Peripartum myocarditis and cardiomyopathy. Circulation. 1990;81:922–8.CrossRefPubMedGoogle Scholar
  32. 32.
    Mielniczuk LM, Williams K, Davis DR, et al. Frequency of peripartum cardiomyopathy. Am J Cardiol. 2006;97(12):1765–8.CrossRefPubMedGoogle Scholar
  33. 33.
    Moioli M, Menada MV, Bentivoglio G, Ferrero S. Peripartum cardiomyopathy. Arch Gynecol Obstet. 2010;281(2):183–8. doi: 10.1007/s00404-009-1170-5.CrossRefPubMedGoogle Scholar
  34. 34.
    Ntusi NB, Chin A. Characterisation of peripartum cardiomyopathy by cardiac magnetic resonance imaging. Eur Radiol. 2009;19(6):1324–5.CrossRefPubMedGoogle Scholar
  35. 35.
    Ntusi NB, Mayosi BM. Aetiology and risk factors of peripartum cardiomyopathy: a systematic review. Int J Cardiol. 2009;131(2):168–79.CrossRefPubMedGoogle Scholar
  36. 36.
    Palanzo DA, Baer LD, El-Banayosy A, et al. Successful treatment of peripartum cardiomyopathy with extracorporeal membrane oxygenation. Perfusion. 2009;24(2):75–9.CrossRefPubMedGoogle Scholar
  37. 37.
    Pearl W. Familial occurrence of peripartum cardiomyopathy. Am Heart J. 1995;129(2):421–2.CrossRefPubMedGoogle Scholar
  38. 38.
    Pearson G, Veille J, Rahimtoola S, et al. Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. JAMA. 2000;283(9):1183–8.CrossRefPubMedGoogle Scholar
  39. 39.
    Pyatt JR, Dubey G. Peripartum cardiomyopathy: current understanding, comprehensive management review and new developments. Postgrad Med J. 2011;87(1023):34–9.CrossRefPubMedGoogle Scholar
  40. 40.
    Ramaraj R, Sorrell VL. Peripartum cardiomyopathy: causes, diagnosis, and treatment. Cleve Clin J Med. 2009;76(5):289–96.CrossRefPubMedGoogle Scholar
  41. 41.
    Rasmusson K, de Jong M, Doering L. Update on heart failure management. Current understanding of peripartum cardiomyopathy. Prog Cardiovasc Nurs. 2007;22(4):214–6.CrossRefPubMedGoogle Scholar
  42. 42.
    Sliwa K, Hilfiker-Kleiner D, Petrie MC, et al. Heart Failure Association of the European Society of Cardiology Working Group on Peripartum Cardiomyopathy. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on Peripartum Cardiomyopathy. Eur J Heart Fail. 2010;12(8):767–78.Google Scholar
  43. 43.
    Smith IJ, Gillham MJ. Fulminant peripartum cardiomyopathy rescue with extracorporeal membranous oxygenation. Int J Obstet Anesth. 2009;18(2):186–8.CrossRefPubMedGoogle Scholar
  44. 44.
    Williams J, Mozurkewich E, Chilimigras J, Van De Ven C. Critical care in obstetrics: pregnancy-specific conditions. Best Pract Res Clin Obstet Gynaecol. 2008;22(5):825–46.CrossRefPubMedGoogle Scholar
  45. 45.
    Fett JD. Earlier detection can help avoid many serious complications of peripartum cardiomyopathy. Future Cardiol. 2013;9:809–16. PMID: 24180539. doi: 10.2217/fca.13.63.
  46. 46.
    Kamiya CA, Kitakaze M, Ishibashi-Ueda H, Nakatani S, Murohara T, Tomoike H, Ikeda T. Different characteristics of peripartum cardiomyopathy between patients complicated with and without hypertensive disorders. results from the Japanese Nationwide survey of peripartum cardiomyopathy. Circ J. 2011;75:1975–81 [PMID: 21617320].CrossRefPubMedGoogle Scholar
  47. 47.
    Okamoto H, Takenaka T, Saitoh Y. Is hypertensive disorder a unique risk factor for peripartum cardiomyopathy and pregnancy-associated cardiomyopathy? Circ J. 2011;75:1827–8 [PMID: 21727752].CrossRefPubMedGoogle Scholar
  48. 48.
    Harper MA, Meyer RE, Berg CJ. Peripartum cardiomyopathy: population-based birth prevalence and 7-year mortality. Obstet Gynecol. 2012;120:1013–9 [PMID: 23090517].PubMedGoogle Scholar
  49. 49.
    Fuster V, American Heart Association, editors. The AHA guidelines and scientific statements handbook. Oxford: Wiley- Black-well; 2009.Google Scholar
  50. 50.
    McTiernan C, Hanley-Yanez K, Pisarcik JE, Morel PA, Cooper LT, Elkayam E, Fett JD, McNamara DM. Activation of cellular immunity in peripartum cardiomyopathy: results of the multicenter IPAC Registry. Circulation. 2011;124:A14173, Supplement vol 124.Google Scholar
  51. 51.
    Cooper LT, Mather PJ, Alexis JD, Pauly DF, Torre-Amione G, Wittstein IS, Dec GW, Zucker M, Narula J, Kip K, McNamara DM. Myocardial recovery in peripartum cardiomyopathy: prospective comparison with recent onset cardiomyopathy in men and nonperipartum women. J Card Fail. 2012;18:28–33 [PMID: 22196838. doi:  10.1016/j.cardfail.2011.09.009].
  52. 52.
    McTiernan C, Hanley-Yanez K, Cooper LT, Rajagopalan N, Thohan V, Zucker M, Boehmer J, Bozkurt B, Mather P, Thornton J, Ghali J, Pisarcik J, Fett JD, Morel J, McNamara D. Racial differences in circulating Natural Killer cells in peripartum cardiomyopathy: results of the NHLBI-sponsored IPAC investigation. Circulation. 2013;128 (Suppl 22): Abstract 16587.Google Scholar
  53. 53.
    Sliwa K, Förster O, Libhaber E, Fett JD, Sundstrom JB, Hilfiker-Kleiner D, Ansari AA. Peripartum cardiomyopathy: inflammatory markers as predictors of outcome in 100 prospectively studied patients. Eur Heart J. 2006;27:441–6 [PMID: 16143707].CrossRefPubMedGoogle Scholar
  54. 54.
    Ellis JE, Ansari AA, Fett JD, Carraway RD, Randall HW, Mosunjac MI, Sundstrom JB. Inhibition of progenitor dendritic cell maturation by plasma from patients with peripartum cardiomyopathy: role in pregnancy-associated heart disease. Clin Dev Immunol. 2005;12:265–73 [PMID: 16584112].CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer India 2016

Authors and Affiliations

  1. 1.Department of OBGAl-Ameen Medical CollegeBijapurIndia
  2. 2.Consultant Cardiologist, Department of CardiologyApollo Group of HospitalsBangaloreIndia

Personalised recommendations